Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase src'

Search results for: 'research area tyrosine kinase src'

Items 1-10 of 78

Page
per page
  1. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src family tyrosine kinase inhibitor
  2. Saracatinib (AZD0530)
    A2133 Saracatinib (AZD0530)
     3 Citation
    Target: Src
    Summary: Src/Abl inhibitor,potent and selective
      ≥27.1 mg/mL
  3. NVP-BHG712
    A8683 NVP-BHG712
    Target: Eph Receptors|VEGFR
    Summary: EphB4 inhibitor,potent and selective
      ≥25.15 mg/mL
  4. Tie2 kinase inhibitor
    A5979 Tie2 kinase inhibitor
    Target: Tie-2
    Summary: Tie-2(Tie2 ) inhibitor
      ≥22 mg/mL
  5. Masitinib (AB1010)
    A2942 Masitinib (AB1010)
    Target: PDGFR|c-Kit|Lyn
    Summary: Tyrosine kinase inhibitor, potent and selective
      ≥24.95 mg/mL
  6. Tivozanib (AV-951)
    A2251 Tivozanib (AV-951)
    Target: VEGFR
    Summary: VEGFR inhibitor,potent and selective
      ≥22.75 mg/mL
  7. R406
    A8546 R406
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and ATP-competitive
      ≥31.45 mg/mL
  8. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  9. Nilotinib(AMN-107)
    A8232 Nilotinib(AMN-107)
     1 Citation
    Target: Bcr-Abl
    Summary: Bcr-Abl kinase inhibitor,selective
      ≥26.5 mg/mL
  10. PF-562271
    A8310 PF-562271
     1 Citation
    Target: FAK|Pyk2
    Summary: ATP-competitive FAK inhibitor, reversible
      ≥25.35 mg/mL

Items 1-10 of 78

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
  3. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 4item
  2. Axl 4item
  3. ALK 6item
  4. c-FMS 1 item
  5. c-Kit 2item
  6. c-MET 8item
  7. c-RET 1 item
  8. CSF-1R 2item
  9. EGFR 9item
  10. FAK 3item
  11. FGFR 6item
  12. FLT3 5item
  13. HER2 5item
  14. IGF1R 3item
  15. ITK 1 item
  16. LRRK2 3item
  17. PDGFR 8item
  18. Pyk2 2item
  19. Spleen Tyrosine Kinase (Syk) 5item
  20. Src 4item
  21. Tie-2 2item
  22. Trk 2item
  23. VEGFR 15item
Reversibility
  1. Reversible 7item
  2. Irreversible 2item
Target
  1. Raf 3item
  2. Aurora Kinases 1 item
  3. CSF-1R 2item
  4. FLT3 5item
  5. Eph Receptors 1 item
  6. VEGFR 18item
  7. PDGFR 11item
  8. c-Kit 6item
  9. RET 3item
  10. Bcr-Abl 6item
  11. FGFR 6item
  12. MET 5item
  13. Src 4item
  14. Trk Receptors 2item
  15. EGFR 9item
  16. FAK 3item
  17. BMP and Other Activin Receptors 1 item
  18. JAK 2item
  19. Syk 5item
  20. ErbB 2item
  21. c-MET 5item
  22. Lyn 1 item
  23. HER2 2item
  24. Pyk2 3item
  25. LRRK2 3item
  26. Insulin and Insulin-like Receptors 2item
  27. ALK 3item
  28. ROS1 1 item
  29. Insulin-like growth factors (IGFs) 1 item
  30. Tie-2 1 item
  31. Insulin Receptors 1 item
  32. IRG-1R 1 item
  33. ZAP-70 1 item
  34. TAM kinase 1 item
  35. AXL 1 item
  36. c-Fms tyrosine kinase 1 item
  37. Lyn kinase 1 item
  38. ITK 1 item
  39. DCLK2 1 item
  40. tropomyosin receptor kinase 1 item
  41. Insulin Receptor 1 item
Related Disease
  1. Acute Myeloid Leukemia 5item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 17item
  7. Cancer 58item
  8. Cervical Cancer 1 item
  9. Cholangiocarcinoma 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 2item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 10item
  14. Glioblastoma 5item
  15. Glioma 3item
  16. Hepatocellular Carcinoma 3item
  17. Leukemia 2item
  18. Liver Cancer 2item
  19. Lung Cancer 5item
  20. Lung Carcinoma 3item
  21. Lymphoma 5item
  22. Melanoma 2item
  23. Multiple Myeloma 3item
  24. Neuroblastoma 1 item
  25. Non-small Cell Lung Cancer 3item
  26. Ovarian Cancer 6item
  27. Pancreatic Cancer 9item
  28. Prostate Cancer 7item
  29. Pulmonary Arterial Hypertension 1 item
  30. Renal Cancer 2item
  31. Renal Cell Carcinoma 4item
  32. Rheumatoid Arthritis 2item
  33. Thyroid Cancer 3item